NO Jimtash, it just means that Radient is not going to sell Onko Sure in the USA any longer.
It certainly makes sense because GenWay dropped the product from their website and an email from Grifols sated they no longer had any connection with Radient. Why waste $2,600 to maintain the approval to sell in the USA.
If Gartner was going to market Onko Sure, he would certainly need the product to be approved so that throws your wild theories out the window.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.